Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors
Status:
Terminated
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
To assess the effect of single pill therapy on the management of hypertension and other
cardiovascular risk factors (e.g., dyslipidemia) in Indian patients in whom the treating
doctor has already considered that the administration of the amlodipine/atorvastatin single
pill to be appropriate
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Amlodipine Amlodipine, atorvastatin drug combination Atorvastatin Atorvastatin Calcium